Stockreport

Alnylam Pharmaceuticals Touts AMVUTTRA Momentum, Teases Key Pipeline Readouts at TD Cowen Conf. [Yahoo! Finance]

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview
PDF and mid-to-high-20s first-line share, and it reiterated 2026 TTR franchise revenue guidance of $4.4–$4.7 billion under its Alnylam 2030 growth framework. Nucresiran TR [Read more]